Stay updated on Pembrolizumab in MSI Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added revision v3.4.3 to the history and removed revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:06:03.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page history shows a new revision (v3.4.2) and removal of the previous revision (v3.4.1), indicating a minor platform update with no visible changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:41:42.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A new revision tag, v3.4.1, was added to the history, replacing v3.4.0, which is a minor update with no changes to study data or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:32:06.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Non-significant UI updates include showing the glossary option, color-coded change indicators and revision labeling (v3.4.0 replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-01-28T21:05:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 to the record history. Removed Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T04:05:56.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.3.3, was added to the record history. The HHS Vulnerability Disclosure and Revision: v3.3.2 elements were removed from the footer; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:05:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.